Skip to main content

Illumina to Market GenoLogics' Geneus LIMS

Premium

GenoLogics said this week that Illumina will market a version of its Geneus Laboratory Information Management System software that is preconfigured to handle data from Illumina's HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits.

The Canadian firm said that its software will enable Illumina users to automate workflows, track library preparations and instrument runs, and prepare basic reports within weeks rather than months.

GenoLogics CEO Michael Ball noted that the combined efforts of the two firms will enable sequencing laboratories to deploy instrumentation and data management tools simultaneously, thus addressing a data-related bottleneck highlighted in a recent survey conducted by JP Morgan.

GenoLogics noted that 63 percent of NGS laboratory directors who participated in the survey identified data storage, data management, and informatics as the "biggest hurdles to expanding next-generation sequencing."

Ball noted that the current arrangement follows an earlier preferred partner agreement between the two companies that made it possible for his firm to develop a version of the LIMS software that is "complementary" to Illumina's sequencing platforms and sample prep kits.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.